Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Choose an application
Bovine leukaemia virus --- Mutagenesis --- pathogenesis --- Viability
Choose an application
Sheep --- Sheep --- Bovine leukaemia virus --- Bovine leukaemia virus --- Live vaccines --- Live vaccines --- Efficiency --- Efficiency
Choose an application
Sheep --- Sheep --- Bovine leukosis --- Bovine leukosis --- Bovine leukaemia virus --- Bovine leukaemia virus --- Mutagenicity --- Mutagenicity --- Pathogenicity --- Pathogenicity
Choose an application
Choose an application
Retroviridae --- Bovine leukosis --- genetic variation --- Bovine leukaemia virus
Choose an application
Enzyme inhibitors --- Enzyme inhibitors --- Histones --- Histones --- Bovine leukaemia virus --- Bovine leukaemia virus --- lymphocytes --- lymphocytes --- Defence mechanisms --- Defence mechanisms --- gene expression --- gene expression --- In vitro experimentation --- In vitro experimentation --- In vivo experimentation --- In vivo experimentation
Choose an application
Bovine Leukaemia Virus (BLV) is a retrovirus that infect cattle, yak, water buffalo and zebu. The most common manifestation of the virus is an accumulation of infected B lymphocytes called persistent lymphocytosis (PL). This virus is present all over the world except in western Europe where a large campaign of testing and euthanasia of infected animals has been conducted. BLV economic impact is estimated at US$525 million due to a loss of milk production but also to a shorter animal lifespan. Preventive actions implemented to limit the spread of the virus often fail due to a lack of commitment to the programme. Therefore, a vaccine is urgently needed to facilitate herd management and disease control. A safe and effective vaccine based on an attenuated BLV strain (pBLV6073DX) has recently been developed. However, the current inoculation technique based on purified DNA does not allow for large-scale vaccination. In this context, the objective of this master thesis is to obtain a cell line expressing the vaccine strain in order to consider its larger-scale production. For this purpose, Vero cells were either transfected with the proviral insert or transduced with viral particles. After sorting with a flow cytometer and PCR-based clone selection, a cell line having stably integrated the vaccine sequence was isolated. Inoculation of sheep with this cell line effectively transmitted the vaccine strain, providing the proof-of-concept of the approach.
Listing 1 - 8 of 8 |
Sort by
|